C3j Therapeutics

Developing phage therapeutics to combat antibiotic-resistant bacterial infections

placeLos Angeles, California, United States calendar_todayFounded 2006 groups60 employees language c3jtherapeutics.com

Registered entities

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace steady. Cited 221 times.

YearFilings
20171
20181
20191
20201
20211
20221
20241
20251

Investor mix

3 investors on record; lead investors include Renaissance Acquisition Holdings.

Investor typeCountShare
Other / undisclosed3100%
Coming soon